HeartSciences (HSCS) EBIT Margin (2021 - 2025)
Historic EBIT Margin for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to 85713.23%.
- HeartSciences' EBIT Margin fell 874012100.0% to 85713.23% in Q4 2025 from the same period last year, while for Oct 2025 it was 2314.37%, marking a year-over-year decrease of 36381400.0%. This contributed to the annual value of 192013.13% for FY2025, which is 1581111400.0% down from last year.
- According to the latest figures from Q4 2025, HeartSciences' EBIT Margin is 85713.23%, which was down 874012100.0% from 98637.84% recorded in Q3 2025.
- HeartSciences' EBIT Margin's 5-year high stood at 9214.54% during Q3 2024, with a 5-year trough of 98637.84% in Q3 2025.
- For the 5-year period, HeartSciences' EBIT Margin averaged around 30478.53%, with its median value being 25266.6% (2024).
- As far as peak fluctuations go, HeartSciences' EBIT Margin skyrocketed by 567670000bps in 2024, and later tumbled by -1078523800bps in 2025.
- HeartSciences' EBIT Margin (Quarter) stood at 9011.84% in 2021, then tumbled by -396bps to 44690.53% in 2022, then rose by 10bps to 40254.95% in 2023, then soared by 104bps to 1687.98% in 2024, then tumbled by -5178bps to 85713.23% in 2025.
- Its EBIT Margin stands at 85713.23% for Q4 2025, versus 98637.84% for Q3 2025 and 1061.86% for Q2 2025.